AT

Annalisa Taddeo

Quality System Management And Plant at Bormioli Pharma

Annalisa Taddeo has extensive experience in quality management and nutrition. Currently serving as Quality System Management and Plant at Bormioli Pharma since June 2019, Annalisa develops and maintains corporate quality management systems in compliance with ISO standards. Previously, as a Quality Assurance Specialist, Annalisa conducted and managed ISO audits. At GSK, Annalisa worked as an Operational Quality Manufacturing Specialist, focusing on quality control for sterile product production while ensuring compliance with GMP regulations. Annalisa's earlier career includes independent nutritional consulting and roles at various hospitals, providing nutritional advice and management. With a Master's degree in Medical Biotechnologies and Molecular Medicine from Università degli Studi di Palermo and a Bachelor's in Medical Biotechnologies from Università degli Studi di Milano, Annalisa combines a strong scientific background with practical expertise.

Location

Parma, Italy

Links


Org chart

No direct reports

Teams


Offices


Bormioli Pharma

Established in 1825, Bormioli Pharma is a leading Italian pharma primary packaging manufacturer. Bormioli Pharma works closely with the pharmaceutical industry and all companies that are working towards the future of healthcare globally. As a world-renowned player in the packaging industry, the company serves the pharmaceutical and biopharmaceutical markets with complete solutions, including glass and plastic bottles, plastic and aluminum closures and accessories. Bormioli Pharma’s wide product ranges are designed and manufactured looking forward innovation and addressing ever-growing sustainability issues. Moreover, each product is specifically conceived for the destination market thanks to an accurate portfolio segmentation. Bormioli Pharma has a global presence in over 100 countries, with more than 1,400 employees and 9 plants across Europe specialized in the production of glass and plastic packaging. Each year, the company produces more than 7 billion pieces and in 2022 reported annual sales of approximately 315 million euros. As a partner to the pharmaceutical industry, Bormioli Pharma invests and innovates with one goal in mind: making health a positive practice, available to everyone, kind to the planet.